RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638,315 | -57.8% | 591,032 | -49.6% | 0.00% | – |
| Q2 2023 | $1,513,471 | +213.6% | 1,173,233 | +220.9% | 0.00% | – |
| Q1 2023 | $482,610 | -9.5% | 365,614 | +2.9% | 0.00% | – |
| Q4 2022 | $533,063 | +85.7% | 355,375 | +46.1% | 0.00% | – |
| Q3 2022 | $287,000 | -42.5% | 243,162 | -44.9% | 0.00% | – |
| Q2 2022 | $499,000 | -43.5% | 441,260 | +49.5% | 0.00% | – |
| Q1 2022 | $883,000 | -73.0% | 295,254 | -76.1% | 0.00% | – |
| Q4 2021 | $3,268,000 | +33.7% | 1,232,834 | +83.1% | 0.00% | – |
| Q3 2021 | $2,444,000 | -32.0% | 673,248 | -18.7% | 0.00% | – |
| Q2 2021 | $3,594,000 | +106.0% | 828,224 | +62.4% | 0.00% | – |
| Q1 2021 | $1,745,000 | -55.6% | 509,969 | -54.5% | 0.00% | – |
| Q4 2020 | $3,926,000 | +84.5% | 1,121,958 | +26.5% | 0.00% | – |
| Q3 2020 | $2,128,000 | +1442.0% | 887,095 | +1076.3% | 0.00% | – |
| Q2 2020 | $138,000 | -29.9% | 75,414 | -40.2% | 0.00% | – |
| Q1 2020 | $197,000 | +56.3% | 126,156 | +114.4% | 0.00% | – |
| Q4 2019 | $126,000 | -50.6% | 58,830 | -56.8% | 0.00% | – |
| Q3 2019 | $255,000 | -90.8% | 136,270 | -87.2% | 0.00% | – |
| Q2 2019 | $2,773,000 | +453.5% | 1,062,449 | +444.8% | 0.00% | – |
| Q1 2019 | $501,000 | -38.6% | 195,000 | -45.0% | 0.00% | – |
| Q4 2018 | $816,000 | +11.2% | 354,611 | +55.3% | 0.00% | – |
| Q3 2018 | $734,000 | +30.6% | 228,400 | +15.0% | 0.00% | – |
| Q2 2018 | $562,000 | -86.8% | 198,600 | -83.5% | 0.00% | -100.0% |
| Q1 2018 | $4,256,000 | +499.4% | 1,202,200 | +557.2% | 0.00% | – |
| Q4 2017 | $710,000 | +166.9% | 182,930 | +75.1% | 0.00% | – |
| Q3 2017 | $266,000 | -44.9% | 104,443 | -40.9% | 0.00% | – |
| Q2 2017 | $483,000 | +38.4% | 176,624 | +67.4% | 0.00% | – |
| Q1 2017 | $349,000 | -53.2% | 105,492 | -66.3% | 0.00% | – |
| Q4 2016 | $745,000 | +55.9% | 312,738 | +140.0% | 0.00% | – |
| Q3 2016 | $478,000 | +72.6% | 130,330 | +4.8% | 0.00% | – |
| Q2 2016 | $277,000 | +319.7% | 124,326 | +290.3% | 0.00% | – |
| Q1 2016 | $66,000 | -48.4% | 31,852 | -24.3% | 0.00% | – |
| Q4 2015 | $128,000 | +43.8% | 42,091 | +17.1% | 0.00% | – |
| Q3 2015 | $89,000 | -77.2% | 35,951 | -70.4% | 0.00% | – |
| Q2 2015 | $390,000 | +98.0% | 121,443 | +119.8% | 0.00% | – |
| Q1 2015 | $197,000 | +203.1% | 55,263 | +94.3% | 0.00% | – |
| Q4 2014 | $65,000 | +4.8% | 28,438 | -11.4% | 0.00% | – |
| Q3 2014 | $62,000 | -66.5% | 32,107 | -37.1% | 0.00% | – |
| Q2 2014 | $185,000 | -73.9% | 51,076 | -72.1% | 0.00% | – |
| Q1 2014 | $710,000 | -46.1% | 182,899 | -60.5% | 0.00% | – |
| Q4 2013 | $1,318,000 | +111.2% | 462,458 | +165.1% | 0.00% | – |
| Q3 2013 | $624,000 | +80.9% | 174,464 | +69.1% | 0.00% | – |
| Q2 2013 | $345,000 | – | 103,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |